These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 26412358)

  • 1. Nano-Therapeutics for the Lung: State-of-the-Art and Future Perspectives.
    Iyer R; Hsia CC; Nguyen KT
    Curr Pharm Des; 2015; 21(36):5233-44. PubMed ID: 26412358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary delivery of anti-inflammatory agents.
    Ali ME; McConville JT; Lamprecht A
    Expert Opin Drug Deliv; 2015 Jun; 12(6):929-45. PubMed ID: 25534260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can nanotechnology hit the spot in aerosol-based drug delivery for lung disorders?
    Joshi N
    Ther Deliv; 2018 Mar; 9(4):233-236. PubMed ID: 29495926
    [No Abstract]   [Full Text] [Related]  

  • 4. General overview of lipid-polymer hybrid nanoparticles, dendrimers, micelles, liposomes, spongosomes and cubosomes.
    Wakaskar RR
    J Drug Target; 2018 Apr; 26(4):311-318. PubMed ID: 28797169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nano- and micro-based inhaled drug delivery systems for targeting alveolar macrophages.
    Lee WH; Loo CY; Traini D; Young PM
    Expert Opin Drug Deliv; 2015 Jun; 12(6):1009-26. PubMed ID: 25912721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled Nanoparticulate Systems: Composition, Manufacture and Aerosol Delivery.
    Mansour HM; Muralidharan P; Hayes D
    J Aerosol Med Pulm Drug Deliv; 2024 Aug; 37(4):202-218. PubMed ID: 39172256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comprehensive Review on Role of Nanoparticles in Therapeutic Delivery of Medicine.
    Rathor S; Bhatt DC; Aamir S; Singh SK; Kumar V
    Pharm Nanotechnol; 2017; 5(4):263-275. PubMed ID: 29141578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nano-delivery to the lung - by inhalation or other routes and why nano when micro is largely sufficient?
    Forest V; Pourchez J
    Adv Drug Deliv Rev; 2022 Apr; 183():114173. PubMed ID: 35217112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Update on Biomedical Application of Nanotechnology for Alzheimer's Disease Diagnosis and Therapy.
    Panahi Y; Mohammadhosseini M; Abadi AJ; Akbarzadeh A; Mellatyar H
    Drug Res (Stuttg); 2016 Nov; 66(11):580-586. PubMed ID: 27701713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micro- and nanocarrier-mediated lung targeting.
    Kurmi BD; Kayat J; Gajbhiye V; Tekade RK; Jain NK
    Expert Opin Drug Deliv; 2010 Jul; 7(7):781-94. PubMed ID: 20560777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary drug delivery: a role for polymeric nanoparticles?
    d'Angelo I; Conte C; Miro A; Quaglia F; Ungaro F
    Curr Top Med Chem; 2015; 15(4):386-400. PubMed ID: 25579350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary delivery of insulin by liposomal carriers.
    Huang YY; Wang CH
    J Control Release; 2006 Jun; 113(1):9-14. PubMed ID: 16730838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanotechnological Systems and Lung: A Perfect Combination for Lung Pharmaceutical Applications.
    Santonocito D; Puglia C
    Curr Med Chem; 2023; 30(6):725-743. PubMed ID: 36043745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered nanoparticles as precise drug delivery systems.
    Yih TC; Al-Fandi M
    J Cell Biochem; 2006 Apr; 97(6):1184-90. PubMed ID: 16440317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational approaches to the rational design of nanoemulsions, polymeric micelles, and dendrimers for drug delivery.
    Huynh L; Neale C; Pomès R; Allen C
    Nanomedicine; 2012 Jan; 8(1):20-36. PubMed ID: 21669300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-based carriers: manufacturing and applications for pulmonary route.
    Jaafar-Maalej C; Elaissari A; Fessi H
    Expert Opin Drug Deliv; 2012 Sep; 9(9):1111-27. PubMed ID: 22724618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging trends in the novel drug delivery approaches for the treatment of lung cancer.
    Sharma P; Mehta M; Dhanjal DS; Kaur S; Gupta G; Singh H; Thangavelu L; Rajeshkumar S; Tambuwala M; Bakshi HA; Chellappan DK; Dua K; Satija S
    Chem Biol Interact; 2019 Aug; 309():108720. PubMed ID: 31226287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymer- and liposome-based nanoparticles in targeted drug delivery.
    Venkatraman SS; Ma LL; Natarajan JV; Chattopadhyay S
    Front Biosci (Schol Ed); 2010 Jun; 2(3):801-14. PubMed ID: 20515826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tweaking dendrimers and dendritic nanoparticles for controlled nano-bio interactions: potential nanocarriers for improved cancer targeting.
    Bugno J; Hsu HJ; Hong S
    J Drug Target; 2015; 23(7-8):642-50. PubMed ID: 26453160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.